Work

Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma

Year: 2018

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2018.1459609

Authors: Shaji Kumar, Brian Durie, Hareth Nahi, Ravi Vij, Meletios A. Dimopoulos, Efstathios Kastritis, Evangelos Terpos, Xavier Leleu, Meral Beksac, Hartmut Goldschmidt, Jens Hillengass, Zhuo Su, Brian Hutton, Chris Cameron, Imran Khan, Annette Lam

Institutions: Mayo Clinic, Cedars-Sinai Medical Center, Karolinska Institutet, Washington University in St. Louis, National and Kapodistrian University of Athens, Centre Hospitalier Universitaire de Poitiers, Ankara University, Heidelberg University, National Center for Tumor Diseases, Roswell Park Comprehensive Cancer Center, Johns Hopkins University, University of Ottawa, Ottawa Hospital Research Institute, Janssen Research & Development (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2800826982

FWCI: 1.215

Cites: 19

Cited by: 13

Related to: 10